PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery

Curr Drug Targets. 2011 Jul 1;12(8):1131-50. doi: 10.2174/138945011795906642.

Abstract

Nanotechnology provides researchers with new tools for cancer treatment. Biodegradable polymeric nanoparticles, as an advanced drug delivery system, have promising applications in cancer treatment. Poly(ε-caprolactone)/poly(ethylene glycol) (PCL/PEG) copolymers are biodegradable and amphiphilic, and show potential application in drug delivery. In recent years, PCL/PEG copolymeric nanoparticles, as a potential nanoplatform for anticancer agent delivery, received increasing attention. This paper reviews PCL/PEG copolymer nanoparticles for anticancer agent delivery, including overcoming water insolubility of hydrophobic drug, targeting chemotherapeutic drug to tumor, and delivering genes, vaccines, and diagnostic agents.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use*
  • Biocompatible Materials
  • Chemistry, Pharmaceutical
  • Drug Carriers / chemistry*
  • Drug Compounding
  • Drug Delivery Systems*
  • Ethylene Glycols / chemistry*
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy
  • Polyesters / chemistry*
  • Solubility

Substances

  • Antineoplastic Agents
  • Biocompatible Materials
  • Drug Carriers
  • Ethylene Glycols
  • Polyesters
  • poly(epsilon-caprolactone)-b-poly(ethylene glycol)